Status:
TERMINATED
Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
Centre Hospitalier Universitaire Vaudois
Conditions:
Liver Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide and is commonly treated with transarterial locoregional therapies (transarterial chemoembolization (TACE) or transarteri...
Eligibility Criteria
Inclusion
- Informed Consent as documented by signature (Appendix Informed Consent Form)
- Male and Female patients ≥18 years of age
- Patients with HCC according to imaging findings and/or histology and scheduled for TACE or TARE
Exclusion
- Women who are pregnant or breast feeding,
- Please note that female participants who are surgically sterilised / hysterectomised or post-menopausal for longer than 2 years are not considered as being of child bearing potential.
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- Previous enrolment into the current study,
- Patients with impaired renal function (estimated glomerular filtration rate \<30 ml/min)
- Patients with non-MRI compatible metallic or electronic implants, devices or metallic foreign bodies (cardiac pacemaker, shrapnel, cochlea implants, neurostimulator, or other non-MRI compatible implants).
- Tumor-directed therapy (i.e. systemic chemotherapy) between transarterial therapy and 3-months follow-up MRI exam
Key Trial Info
Start Date :
September 11 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2019
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04702230
Start Date
September 11 2017
End Date
April 30 2019
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Switzerland